Magnasense
0.041
SEK
-19.37 %
Less than 1K followers
MAGNA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-19.37%
-52.53%
+74.48%
+243.21%
+154.75%
-47.24%
-97.93%
-
-96.76%
Magnasense operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and mainly includes drugs for the treatment of multiple sclerosis. In addition to the main business, associated ancillary services are offered. The business is run in collaboration with other pharmaceutical actors, where the largest presence is found in the Nordic region.
Read moreMarket cap
50.34M SEK
Turnover
295.8K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
30/6
2025
General meeting '25
29/8
2025
Interim report Q2'25
31/3
2026
Annual report '25
All
Press releases
ShowingAll content types
Magnasense resolves on directed issue of units to guarantor in connection with completed rights issue
Kallelse till årsstämma i Magnasense AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools